From bone marrow transplants 5 decades ago to the most recent stem cell—derived organ
transplants, regenerative medicine is increasingly recognized as an emerging core …

Cardiovascular diseases remain the major cause of death in the Western world. 1 Stem and
progenitor cell (SPC)–based therapies in animal models and human trials in recent years …

Aims Comparison of intracoronary infusion of bone marrow (BM)-derived unselected
mononuclear cells (UNSEL) and selected CD34+ CXCR4+ cells (SEL) in patients with acute …

Aims We assessed whether a single intracoronary infusion of autologous bone marrow cells
(BMCs) can have a sustained impact on left ventricular ejection fraction (LVEF) in patients …

The administration of therapeutic cell types, such as stem and progenitor cells, has gained
much interest for the limitation or repair of tissue damage caused by a variety of insults …

Objectives: The aim of this study was to investigate the quantitative amount of improvement
of ventricular hemodynamic status, geometry, and contractility as well as the long-term …

Myocardial infarction is a major public health problem that causes significant mortality
despite recent advances in its prevention and treatment. Therefore, approaches based on …

Aims Recent clinical studies revealed that positive results of cell transplantation on cardiac
function are limited to the short-and mid-term restoration phase following myocardial …

Objective: To investigate long-term safety and efficacy after intracoronary injection of
autologous mononuclear bone marrow cells (mBMCs) in acute myocardial infarction (AMI) …

Aims To evaluate the safety profile and efficacy of bone marrow mononuclear cells
(BMMNC) transplantation for ST-segment elevation myocardial infarction (STEMI) by …